Risk Factors for Mechanical Failure After Spinal Fusion : an Observational Study

The aim of this of study is to identify the incidence of mechanical failures after spinal fusion within one year of surgery and to assess the related risk factors.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Spinal Fusion Bone Diseases Musculoskeletal Diseases Spinal Diseases Spine Disease Surgery--Complications

Sex eligibility

All sexes

Study type

Observational

Primary location

Vincenzo Peccerillo

Bologna, BO, 40141, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patients undergoing spine fusion and followed up for clinical checks in the year following the surgery .

Exclusion criteria

patients undergoing spine surgery without the application of instrumentation

Treatment and study plan

Spinal Fusion

Procedure

patients undergoing spinal fusion

Primary outcomes

incidence of mechanical failure

Time frame: up to 1 year from the surgery

number of mechanical failure / total number of spinal fusion performed

Secondary outcomes

deambulation performed during hospitalization

Time frame: up to the first day(up to 1 day) for ambulation from the surgery

number of patients that are able to achieve ambulation after surgery

Sponsors and collaborators

Lead sponsor

Istituto Ortopedico Rizzoli

Other

Registry information

Acronym: RachideMDS

Important dates

Study start: 2021
Primary completion: 2021
Study completion: 2021
First posted: Jul 30, 2021
Registry last updated: Mar 31, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed